Table 1.
Participant, treatment, and tumor characteristics
| Characteristic | N | Value (%) |
|---|---|---|
|
| ||
| Age, years (mean ± standard deviation) | 56.0 ± 13.6 | |
|
| ||
| Sex | ||
| Female | 12 | 46.2% |
| Male | 14 | 53.8% |
|
| ||
| Employment Status | ||
| Employed | 18 | 69.2% |
| Unemployed | 4 | 15.4% |
| Retired | 4 | 15.4% |
|
| ||
| Marital Status | ||
| Married | 14 | 53.8% |
| Single | 8 | 30.8% |
| Widowed | 4 | 15.4% |
|
| ||
| Neoadjuvant treatments | ||
| Radiation and chemotherapy | 12 | 46.2% |
| Radiation alone | 1 | 3.8% |
| Chemotherapy alone | 7 | 26.9% |
| None | 6 | 23.1% |
|
| ||
| Procedure performed | ||
| LAR | 12 | 46.2% |
| LAR and proximal diverting stoma | 2 | 7.7% |
| LAR with CAA and proximal diverting stoma | 12 | 46.2% |
|
| ||
| Final pathological TNM stage* | ||
| Stage 0 | 6 | 23.1% |
| Stage I | 7 | 26.9% |
| Stage II | 6 | 23.1% |
| Stage III | 7 | 26.9% |
LAR low anterior resection, CAA coloanal anastomosis, TNM stage American Joint Commission on Cancer TNM stage.
*
Includes cases treated with neoadjuvant treatment before surgery (ypTNM stage) if applicable.